Selected research
Market Structure
Global Macitentan Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Macitentan Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Macitentan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Macitentan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Macitentan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Macitentan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Macitentan Tablets include Zhengda Tianqing, Sinotherapeutics, Shanghai Pharmaceutical Group, Shanghai Xudong Haipu Pharmaceutical, Qilu Pharmaceutical, Jiangsu Yunyang Group Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, Teva and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Macitentan Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Macitentan Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Macitentan Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Macitentan Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Macitentan Tablets Segment by Company
Zhengda Tianqing
Sinotherapeutics
Shanghai Pharmaceutical Group
Shanghai Xudong Haipu Pharmaceutical
Qilu Pharmaceutical
Jiangsu Yunyang Group Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
Teva
Mylan
Johnson & Johnson
Dr. Reddy's Laboratories
Macitentan Tablets Segment by Type
Original Drug
Generic Drug
Macitentan Tablets Segment by Application
Hospital
Clinic
Other
Macitentan Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Macitentan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Macitentan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Macitentan Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Macitentan Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macitentan Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Macitentan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Macitentan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital
- Clinic
- Other
Companies covered
- Zhengda Tianqing
- Sinotherapeutics
- Shanghai Pharmaceutical Group
- Shanghai Xudong Haipu Pharmaceutical
- Qilu Pharmaceutical
- Jiangsu Yunyang Group Pharmaceutical
- Hangzhou Zhongmei Huadong Pharmaceutical
- Teva
- Mylan
- Johnson & Johnson
- Dr. Reddy's Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Macitentan Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Macitentan Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Macitentan Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Macitentan Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Macitentan Tablets Market Dynamics
- 2.1 Macitentan Tablets Industry Trends
- 2.2 Macitentan Tablets Industry Drivers
- 2.3 Macitentan Tablets Industry Opportunities and Challenges
- 2.4 Macitentan Tablets Industry Restraints
3 Macitentan Tablets Market by Manufacturers
- 3.1 Global Macitentan Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Macitentan Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Macitentan Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Macitentan Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Macitentan Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Macitentan Tablets Manufacturers, Product Type & Application
- 3.7 Global Macitentan Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Macitentan Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Macitentan Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Macitentan Tablets Tier 1, Tier 2, and Tier 3
4 Macitentan Tablets Market by Type
- 4.1 Macitentan Tablets Type Introduction
- 4.1.1 Original Drug
- 4.1.2 Generic Drug
- 4.2 Global Macitentan Tablets Sales by Type
- 4.2.1 Global Macitentan Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Macitentan Tablets Sales by Type (2021-2032)
- 4.2.3 Global Macitentan Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Macitentan Tablets Revenue by Type
- 4.3.1 Global Macitentan Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Macitentan Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Macitentan Tablets Revenue Market Share by Type (2021-2032)
5 Macitentan Tablets Market by Application
- 5.1 Macitentan Tablets Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Macitentan Tablets Sales by Application
- 5.2.1 Global Macitentan Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Macitentan Tablets Sales by Application (2021-2032)
- 5.2.3 Global Macitentan Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Macitentan Tablets Revenue by Application
- 5.3.1 Global Macitentan Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Macitentan Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Macitentan Tablets Revenue Market Share by Application (2021-2032)
6 Global Macitentan Tablets Sales by Region
- 6.1 Global Macitentan Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Macitentan Tablets Sales by Region (2021-2032)
- 6.2.1 Global Macitentan Tablets Sales by Region (2021-2026)
- 6.2.2 Global Macitentan Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Macitentan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Macitentan Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Macitentan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Macitentan Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Macitentan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Macitentan Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Macitentan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Macitentan Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Macitentan Tablets Revenue by Region
- 7.1 Global Macitentan Tablets Revenue by Region
- 7.1.1 Global Macitentan Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Macitentan Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Macitentan Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Macitentan Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Macitentan Tablets Revenue (2021-2032)
- 7.2.2 North America Macitentan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Macitentan Tablets Revenue (2021-2032)
- 7.3.2 Europe Macitentan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Macitentan Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Macitentan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Macitentan Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Macitentan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zhengda Tianqing
- 8.1.1 Zhengda Tianqing Company Information
- 8.1.2 Zhengda Tianqing Business Overview
- 8.1.3 Zhengda Tianqing Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zhengda Tianqing Macitentan Tablets Product Portfolio
- 8.1.5 Zhengda Tianqing Recent Developments
- 8.2 Sinotherapeutics
- 8.2.1 Sinotherapeutics Company Information
- 8.2.2 Sinotherapeutics Business Overview
- 8.2.3 Sinotherapeutics Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sinotherapeutics Macitentan Tablets Product Portfolio
- 8.2.5 Sinotherapeutics Recent Developments
- 8.3 Shanghai Pharmaceutical Group
- 8.3.1 Shanghai Pharmaceutical Group Company Information
- 8.3.2 Shanghai Pharmaceutical Group Business Overview
- 8.3.3 Shanghai Pharmaceutical Group Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shanghai Pharmaceutical Group Macitentan Tablets Product Portfolio
- 8.3.5 Shanghai Pharmaceutical Group Recent Developments
- 8.4 Shanghai Xudong Haipu Pharmaceutical
- 8.4.1 Shanghai Xudong Haipu Pharmaceutical Company Information
- 8.4.2 Shanghai Xudong Haipu Pharmaceutical Business Overview
- 8.4.3 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Product Portfolio
- 8.4.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments
- 8.5 Qilu Pharmaceutical
- 8.5.1 Qilu Pharmaceutical Company Information
- 8.5.2 Qilu Pharmaceutical Business Overview
- 8.5.3 Qilu Pharmaceutical Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Qilu Pharmaceutical Macitentan Tablets Product Portfolio
- 8.5.5 Qilu Pharmaceutical Recent Developments
- 8.6 Jiangsu Yunyang Group Pharmaceutical
- 8.6.1 Jiangsu Yunyang Group Pharmaceutical Company Information
- 8.6.2 Jiangsu Yunyang Group Pharmaceutical Business Overview
- 8.6.3 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Product Portfolio
- 8.6.5 Jiangsu Yunyang Group Pharmaceutical Recent Developments
- 8.7 Hangzhou Zhongmei Huadong Pharmaceutical
- 8.7.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
- 8.7.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
- 8.7.3 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Product Portfolio
- 8.7.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
- 8.8 Teva
- 8.8.1 Teva Company Information
- 8.8.2 Teva Business Overview
- 8.8.3 Teva Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Teva Macitentan Tablets Product Portfolio
- 8.8.5 Teva Recent Developments
- 8.9 Mylan
- 8.9.1 Mylan Company Information
- 8.9.2 Mylan Business Overview
- 8.9.3 Mylan Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Mylan Macitentan Tablets Product Portfolio
- 8.9.5 Mylan Recent Developments
- 8.10 Johnson & Johnson
- 8.10.1 Johnson & Johnson Company Information
- 8.10.2 Johnson & Johnson Business Overview
- 8.10.3 Johnson & Johnson Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Johnson & Johnson Macitentan Tablets Product Portfolio
- 8.10.5 Johnson & Johnson Recent Developments
- 8.11 Dr. Reddy's Laboratories
- 8.11.1 Dr. Reddy's Laboratories Company Information
- 8.11.2 Dr. Reddy's Laboratories Business Overview
- 8.11.3 Dr. Reddy's Laboratories Macitentan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Dr. Reddy's Laboratories Macitentan Tablets Product Portfolio
- 8.11.5 Dr. Reddy's Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Macitentan Tablets Value Chain Analysis
- 9.1.1 Macitentan Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Macitentan Tablets Production Mode & Process
- 9.2 Macitentan Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Macitentan Tablets Distributors
- 9.2.3 Macitentan Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst